Paradoxical Exacerbation of Psoriasis in AIDS: Proposed Explanations Including the Potential Roles of Substance P and Gram-negative Bacteria

References

• Camp, R.D.R. (1998) "Psoriasis", In: Champion, R.H., Burton, J.L. and Ebling, FLU., eds, Rook/ Wilkinson/ Ebling. Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 4, pp 1589–1649
   Google Scholar
• Lazar, AR and Roenigk, H.H. (1988) "Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis", J. Am. Acad. Dennatol. 18, 144
   PubMed Web of Science ®Google Scholar
• Duvic, M., Johnson, T.M. and Rapini, R.P. (1987) "Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome", Arch. Dennatol. 123, 1622–1632
   Google Scholar
• Colebunders, R., Blot, K., Meriens, V. and Dock, R (1992) "Psoriasis regression in terminal AIDS (letter)", Lancet 339, 1110
   PubMed Web of Science ®Google Scholar
• Lisi, R (1973) "Investigation on Langerhans cells in pathological human epidermis", Acta Dennatol. Venereol. (Stockh) 53,425–428
   PubMedGoogle Scholar
• Haftek, M., Faure, M., Schmitt, D. and Thivolet, J. (1982) "Effects of aromatic retinoid treatment on epidermal Largerhans cells in psoriasis: a quantitative study", J. Invest. Dennatol. 78, 327, (Abstr)
   Google Scholar
• Harper, J.I. and Zemelman, V. (1988) "Cyclosporin for psoriasis: changes in T-cell subsets and Langerhans cells in lesional and non-lesional skin (during a six month treatment period)", In: Van Joost, T.H., Heule, R and Bos, J.D., eds, Cyclosporin in psoriasis (Sandoz Publications), p 109
   Google Scholar
• Zemelman, V., Neer, F.V., Roberts, N., Patel, P., Jangtry, J. and Staughton, R.C.D. (1994) "Epidermal Langerhans cells, HIV-1 infection and psoriasis", Br J. Dennatol. 130, 307–311
   Google Scholar
• Belsito, DV., Sanches, MR., Baer, R., Valentine, R and Thorbeche, G.J. (1984) "Reduced Langerhans cell antigen and ATPase activity in patients with the acquired immunodeficiency syndrome", N. Engl. J. Med. 310, 1279–1282
   PubMedGoogle Scholar
• Ortonne, J.P. (1999) "Recent developments in the understanding of the pathogenesis of psoriasis", Br J. Dennatol. 140\(Suppl. 54), 1–7
   Google Scholar
• Parish, WE. and Breathnach, S.M. (1998) "Clinical immunology and allergy", In: Champion, R.H., Burton, J.L. and Ebling, eds, Rook/ Wilkinson/ Ebling. Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 4, p 292
   Google Scholar
• Placek, W., Haftek, M. and Thivolet, J. (1988) "Sequence of changes in psoriatic epidermis", Acta Denn. Venereol (Stockh) 68, 369–372
   PubMedGoogle Scholar
• Ramirez-Bosca, M., Martinez-Ojeda, L., Valcuende-Cavero, F., et al. (1989) "A study of local immunity in psoriasis", Br. J. Dennatol. 119, 587–595
   Google Scholar
• Mallon, E., Young, D., Bunce, M., Gotch, RM., Easterbrook, P.J., Newson, R. and Bunker, C.B. (1998) "HLA-Cw*0602 and HIV-associated psoriasis", Br J. Dennatol. 139, 527–533
   Google Scholar
• Duvic, M. (1990) "Immunology of AIDS related to psoriasis", J. Invest. Dennatol. 95, 385–405
   Google Scholar
• Leung, DIM., Walsh, R, Giorn, R. and Noris, D.A. (1993) "A potential role for superantigens in the pathogenesis of psoriasis", J. Invest. Dennatol. 100, 225–228
   PubMed Web of Science ®Google Scholar
• Valdimarsson, H., Baker, B.S., Jonsdottir, I., et al. (1995) "Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal syperantigens?", Immunol. Today 16, 145–149
   PubMedGoogle Scholar
• Gottlieb, A.B., Lifshitz, B., Fu, S.M., et al. (1986) "Expression of HLA-DR molecule by keratinocytes and presence of Langerhans' cells in the dermal infiltrate of active psoriatic plaques", J. Exp. Med. 164, 1013–1028
   PubMed Web of Science ®Google Scholar
• Tokura, I, Yagi, J., O'Malley, M., et al. (1994) "Superantigenic staphylococcal exotoxins induce T cell proliferation in presence of Langerhans cells or class 1I-bearing keratinocytes to produce T-cell-activating cytokines", J. Invest. DermatoL 102, 31–38
   PubMedGoogle Scholar
• Aukrust, R, Liabakk, N., Muller, F., et al. (1994) "Serum levels of tumor necrosis factor-a (TNF-a) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunological, and virologic parameters", J. Infect. Dis. 169, 420–424
   PubMed Web of Science ®Google Scholar
• Craven, D.E. (1995) "Staphylococcus aureus colonisation and bacteremia in persons infected with human immunodeficiency virus: a dynamic interaction with the host", J. Chemother. 7\(Suppl. 3), 19–28
   PubMedGoogle Scholar
• Leonard, J.M., Abramczuk, LW., Pezen, D.S., Rutledge, R., Belcher, J.H., Hakim, F., et al. (1988) "Development of disease and virus recovery in transgenic mice containing HIV proviral DNA", Science 242, 1665–1670
   PubMed Web of Science ®Google Scholar
• Duvic, M., Crane, MM., Conant, M., Mahoney, SE., Reveille, J.D. and Lehrman, S.N. (1994) "Zidovudine improves psoriasis in human immunodeficiency virus-positive males", Arch. Dennatol. 130, 447
   Google Scholar
• Bonnekon, B., Wevers, A., Geisel, J., Rasokat, H. and Mahrle, G. (1991) "Antiproliferative potential of zidovudine in human keratinocyte cultures", J. Am. Acad. Dennatol. 25, 483–490
   PubMedGoogle Scholar
• Camisa, C. (1998) "Conditions associated with psoriasis", In: Camisa, C., ed, Handbook of Psoriasis, 1st Ed. (Blackwell Scientific Publications, Oxford), p 69
   Google Scholar
• Kedzierska, K. and Crowe, S.M. (2001) "Cytokines and HIV-1: interactions and clinical implications", Antivir. Chem. Chemother 12(3), 133–150
   PubMedGoogle Scholar
• Emilie, D., Fior, R., Jarrousse, B., Marfaing-Koka, A., Merrien, D., Deverrie, N., Devergne, 0., et al. (1994) "Cytokines in HEY infection", Int. J. ImmunophannacoL 16(5–6), 391–396
   Google Scholar
• Ormerod, A.D., Weller, R., Copeland, R, et al. (1998) "Detection of nitric oxide and nitric synthases in psoriasis", Arch. Dennatol. Res. 290, 3–8
   PubMed Web of Science ®Google Scholar
• Orem, A., Aliyazicioglu, R., Kiran, E., Vanizor, B., Cimnodeirt, G. and Deger, 0. (1997) "The relationship between nitric oxide production and activity of the disease in patients with psoriasis", Arch. Dennatol. 133, 1606–1607
   Google Scholar
• Morhen, V.B. (1997) "Langerhans cells may trigger the psoriatic disease process via production of nitric oxide", Immunol. Today 18(9), 433–436
   Google Scholar
• Pietraforte, D., Tritarelli, E., Testa, U. and Minetti, M. (1994) "gp 1 20 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages", J. Leukoc. Biol. 55(2), 175–182
   PubMedGoogle Scholar
• Evans, T.G., Rasmussen, K., Wiebke, G. and Hibbs, J.B. Jr (1994) "Nitric oxide synthesis in patients with advanced HIV infection", Clin. Exp. Immunol. 97(1), 83–86
   PubMedGoogle Scholar
• Weller, R. (1999) "Nitric oxide, skin growth and differentiation: more questions than answers?", Clin. Exp. Dennatol. 24,388–391
   PubMedGoogle Scholar
• Namazi, M.R. (2003) "A complementary note on the Morhenn's hypothesis on the pathomechanism of psoriasis", Immunol. Lett. 85(3), 223
   Google Scholar
• Jiang, WY, Raychaudhari, S.P. and Farber, E.M. (1988) "Double-labeled immunofluorescence study of cutaneous nerves in psoriasis", Int. J. Dennatol. 37, 572–574
   Google Scholar
• NauRarinen, A., Nickoloff, B.J. and Farber, E.M. (1989) "Quantification of cutaneous sensory nerves and their substance P content in psoriasis", J. Invest. Dennatol. 92, 126–129
   PubMedGoogle Scholar
• Al' abadie, M.S.K., Senior, H.J., Bleehen, S.S., et al. (1992) "Neurogenic changes in psoriasis: an inununohistochemical study", J. Invest. Dennatol. 98, 535
   Google Scholar
• Naukkavinen, A., Harvima, I., Paukkonen, K., et al. (1996) "Immunohistochemical analysis of sensory nerves and neuro-peptides, and their contacts with mast cells in developing and mature psoriatic lesions", Arch Dennatol. Res. 285, 341–346
   Google Scholar
• Farber, EM., Nickoloff, B.J., Reda, B. and Fraki, J.E. (1986) "Stress, symmetry, and psoriasis: possible role of neuropeptides", J. Am. Acad. Dennatol. 14, 305–311
   PubMed Web of Science ®Google Scholar
• Park, Y.M. and Kim, C.W. (1999) "The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes", J. Dennatol. Sci. 22(1), 17–23
   Google Scholar
• Matis, W.L., Lavker, R.M. and Murphy, G.F. (1990) "Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium", J. Invest. Dennatol. 94, 492–495
   PubMed Web of Science ®Google Scholar
• Ansel, J.C., Armstrong, CA., Song, I., Quinlan, K.L., Olerud, J.E., Caughman, S.W., et al. (1997) "Interactions of the skin and nervous system", J. Invest. Dennatol. Symp. Proc. 2(1), 23–26
   Google Scholar
• Eeday, D.J., Johnson, CE, Shaw, C. and Buchanan, K.D. (1991) "Neuropeptides in psoriasis: an immunocytochemical and radio-immunoassay study", J. Invest. Dennatol. 96(4), 434–438
   PubMedGoogle Scholar
• Nilsson, J., Von Euler, AM. and Dalsgaard, C-J. (1985) "Stimulation of connective tissue cell growth by substance P and substance K", Nature 315-61-315–63
   Google Scholar
• Panconesi, E. and Hautmann, G. (1996) "Pathophysiology of stress in dermatology: the psychobiologic pattern of psychosomatics", Dennatol. Qin. 14, 399–421
   Google Scholar
• Farber, EM., Rein, G. and Lanigan, S.W. (1991) "Stress in psoriasis: psychoneuroimmunologic mechanisms", Int. J. Dennatol. 30, 8–12
   Google Scholar
• Smith, CH., Barker, J.N.W.N., Morris, R.W., et al. (1993) "Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin", J. Immunol. 151, 3274–3282
   PubMed Web of Science ®Google Scholar
• Ellis, C.N., Berberian, B., Sulica, V.I., Dodd, WA., Jarratt, MT., Katz, HI., et al. (1993) "A double-blind evaluation of topical capsaicin in pruritic psoriasis", J. Am. Acad. Dennatol. 29,438–442
   PubMed Web of Science ®Google Scholar
• Cotterill, LA. and Millard, L.G. (1998) "Psychosomatic disorders", In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., eds, Rook /Wilkinson/ Ebling Textbook of Dermatology, 6th Ed. (Blackwell Scientific Publications, Oxford) Vol. 2, p 2787
   Google Scholar
• O'Dorisio, M.S. (1988) "Neuropeptide modulation of the immune response in gut associated lymphoid tissue", Int. J. Neurosci. 38, 189–198
   PubMed Web of Science ®Google Scholar
• Rugg, MR., Wahl, S.M. and Pert, C.B. (1985) "Substance P receptor-mediated chemotaxis of human monocytes", Peptides 6\(Suppl. 2), 107–111
   Google Scholar
• Lotz, M., Vaughon, J.H. and Garson, D.A. (1988) "Effect of neuropeptides on production of inflammatory cytokines by human monocytes", Science 241, 1218–1221
   PubMed Web of Science ®Google Scholar
• Bernow, B. (1983) "Substance P", Phannacol. Rev. 35, 85–141
   PubMedGoogle Scholar
• Forman, J.C. (1987) "Substance P and calctionin-gene-related peptide: effects on mast cells and in human skin", Int. Arch Allergy Appl. Immunol. 82, 366–371
   PubMedGoogle Scholar
• Benrath, J., Eschenfelder, C., Zinruneremann, M. and Giillardon, F. (1995) "Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultra-violet irradiation", Eur. J. Phannacol. 293, 87–96
   PubMed Web of Science ®Google Scholar
• Camisa, C. (1998) "Pathogenesis of psoriasis", In: Camisa, C., ed, Handbook of Psoriasis, 1st Ed. (Blackwell Scientific Publications, Oxford), pp 47–49
   Google Scholar
• Douglas, S.D., Ho, W.Z., Getted, DR., Cnaan, A., Zhao, H., Leserman, J., et al. (2001) "Elevated substance P levels in HIV-infected men", AIDS 15(15), 2043–2045 (Abstr.)
   Google Scholar
• Ho, W.Z., Lai, J.P., Li, Y. and Doglas, S.D. (2002) "HEY enhances substance P expression in human immune cells", FASEB J. 16(6), 616–618 (Abstr.)
   Google Scholar
• Stingel, G., Rappersberge, K., Tschachler, E., Gartner, S., Groh, V, Mann, D.L., et al. (1990) "Langerhans' cells in HEY-1 infection", J. Am. Acad. Dennatol. 22, 1210–1217
   PubMedGoogle Scholar
• O'Neill, T.P. (1991) "Mechanism of capsaicin action: recent learnings", Respir. Med.(Suppl. A), 35–41
   Google Scholar
• Li, Y, Douglas, S.D., Song, L., Sun, S. and Ho, W.Z. (2001) "Substance P enhances HEY-1 replication in human immune cells", J. Neuroimmunol. 121(1-2), 67–75
   PubMedGoogle Scholar
• Karhukrpi, J., Ilcaheimo, I., Karvonen, J. and Karttunen, R. (2002) "Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris", Eur. J. Immunogenet. 29, 57–60
   PubMedGoogle Scholar